[Cytoenzymological characteristics of myeloblastic leukemia]

Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.

Bone marrow transplantation·2013

Myeloma cells suppress osteoblasts through sclerostin secretion.

Blood cancer journal·2012

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia.

Oncogene·2010

Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients.

Leukemia·2009

Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML.

Bone marrow transplantation·2008

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

Annals of hematology·2007

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Haematologica·2026

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Haematologica·2026

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Haematologica·2026

Normal platelet function in a patient with ARHGEF1 deficiency.

Haematologica·2026

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Haematologica·2026

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Haematologica·2026

How Much Dissection Is Enough? Mesenteric Vessel Skeletonization Length and Lymph Node Harvest Quality in Rectal Cancer Surgery.

The American surgeon·2026

Follicular lymphoma and the microenvironment: potential targets and biomarkers.

Expert review of clinical immunology·2026

Histotripsy for Hepatocellular Carcinoma: From Bench to Bedside.

Radiology·2026

Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.

Molecular cancer therapeutics·2026

KSHV promotes leukocyte adhesion and transendothelial migration via induction of VCAM1.

mBio·2026

Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.

Cancer reports (Hoboken, N.J.)·2026

Related Experiment Videos

[Cytoenzymological characteristics of myeloblastic leukemia]

Related Concept Videos

Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.

Myeloma cells suppress osteoblasts through sclerostin secretion.

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia.

Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients.

Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML.

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Normal platelet function in a patient with ARHGEF1 deficiency.

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

How Much Dissection Is Enough? Mesenteric Vessel Skeletonization Length and Lymph Node Harvest Quality in Rectal Cancer Surgery.

Follicular lymphoma and the microenvironment: potential targets and biomarkers.

Histotripsy for Hepatocellular Carcinoma: From Bench to Bedside.

Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.

KSHV promotes leukocyte adhesion and transendothelial migration via induction of VCAM1.

Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.

Related Experiment Videos

[Cytoenzymological characteristics of myeloblastic leukemia]

Related Concept Videos

Related Articles